What is Asasantin used for?

What is Asasantin used for?

What Asasantin SR is used for. Asasantin SR contains dipyridamole and aspirin. It is used to help prevent the recurrence of stroke in people who have had a previous stroke or transient ischaemic attack (TIA). This type of medication is called an antithrombotic agent.

Is Asasantin discontinued?

The Australian registered medicine ASASANTIN SR dipyridamole 200mg/aspirin 25mg sustained release capsule bottle AUST R 68051 sponsored by Boehringer Ingelheim Pty Ltd has been discontinued.

Why is dipyridamole discontinued?

Boehringer Ingelheim Pharmaceuticals has announced the permanent discontinuation of Persantine (dipyridamole) tablets and its authorized generics. The decision to discontinue the product is business-related and not due to product safety or efficacy.

What is a substitute for Asasantin?

PATIENTS will continue to have access to a PBS-subsidised dipyridamole and aspirin combination, with the discontinued Asasantin SR able to be substituted with Diasp SR from Arrotex.

What medicines are in short supply in Australia?

The TGA’s current list of critical medicine shortages, among many, includes:

  • the antibiotic gentamicin, used to treat several types of bacterial infections.
  • hydralazine hydrochloride, used to treat high blood pressure.
  • carbimazole, used to treat hyperthyroidism and thyrotoxicosis.

What is the difference between dipyridamole and clopidogrel?

Clopidogrel monotherapy is an alternate to aspirin plus dipyridamole, with a similar risk of bleeding [8, 41–44], while dipyridamole reduces the risk of recurrent stroke without excess bleeding [23]. No previous studies have evaluated the hemorrhagic complications of the clopidogrel–dipyridamole combination.

Is clopidogrel the same as dipyridamole?

What is another name for dipyridamole?

Dipyridamole Brand names: Attia, Ofcram, Persantin, Persantin Retard, Trolactin.

Why is dipyridamole being discontinued?

Is dipyridamole still available?

Nevertheless, based on evidence from this study, dipyridamole is still officially licenced for use as an adjunct to oral anticoagulation for the prophylaxis of thromboembolism associated with prosthetic heart valves.